Fetal Diagnosis and Therapy

Original Paper

Evaluation of an Optimal Gestational Age Cut-Off for the Definition of Early- and Late-Onset Fetal Growth Restriction

Savchev S.a · Figueras F.a,b,d · Sanz-Cortes M.a, b · Cruz-Lemini M.a · Triunfo S.e · Botet F.a-d · Gratacos E.a,b,d

Author affiliations

aFetal and Perinatal Research Centre, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), bMaternal-Fetal Medicine Department and cNeonatal Unit, Hospital Clinic, University of Barcelona, dUniversity of Barcelona, Barcelona, Spain; eDepartment of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy

Related Articles for ""

Fetal Diagn Ther 2014;36:99-105

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: March 21, 2013
Accepted: September 06, 2013
Published online: November 06, 2013
Issue release date: August 2014

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT

Abstract

Objective: The terms early- and late-onset fetal growth restriction (FGR) are commonly used to distinguish two phenotypes characterized by differences in onset, fetoplacental Doppler, association with preeclampsia (PE) and severity. We evaluated the optimal gestational age (GA) cut-off maximizing differences among these two forms. Patients and Methods: A cohort of 656 consecutive singleton pregnancies with FGR was created. We used the decision tree analysis to evaluate the GA cut-off that best discriminated perinatal mortality, association with PE and adverse perinatal outcome (fetal demise, early neonatal death, neonatal acidosis at birth, and 5-min Apgar score <7). Results: We identified 32 weeks at diagnosis as the optimal cut-off, resulting in two groups with 7.1 and 0%, p < 0.001 perinatal mortality, 35.1 and 12.1%, p < 0.001 association with PE, and 13.4 and 4.6%, p < 0.001 composite adverse perinatal outcome. Abnormal versus normal umbilical artery (UA) Doppler classified two groups with 10.6 and 0.2%, p < 0.001 perinatal mortality, 50.0 and 11.8%, p < 0.001 association with PE, and 18.2 and 4.2%, p < 0.001 composite adverse perinatal outcome. Conclusions: UA Doppler discriminated better the two forms of FGR with average early- and late-onset presentation, higher association with PE and poorer outcome. In the absence of UA information, a GA cut-off of 32 weeks at diagnosis maximizes differences between early- and late-onset FGR.

© 2013 S. Karger AG, Basel




Related Articles:


References

  1. Lackman F, Capewell V, Gagnon R, Richardson B: Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol 2001;185:674-682.
  2. Barker DJP: Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006;49:270-283.
  3. Jarvis S, Glinianaia SV, Torrioli M-G, Platt M-J, Miceli M, Jouk P-S, Johnson A, Hutton J, Hemming K, Hagberg G, Dolk H, Chalmers J: Surveillance of Cerebral Palsy in Europe (SCPE) collaboration of European Cerebral Palsy Registers. Cerebral palsy and intrauterine growth in single births: European collaborative study. Lancet 2003;362:1106-1111.
  4. Kady SM, Gardosi J: Perinatal mortality and fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2004;18:397-410.
  5. Baschat AA: Fetal growth restriction - from observation to intervention. J Perinat Med 2010;38:239-246.
  6. GRIT Study Group: A randomised trial of timed delivery for the compromised preterm fetus: short-term outcomes and bayesian interpretation. BJOG 2003;110:27-32.
  7. Baschat AA, Cosmi E, Bilardo CM, Wolf H, Berg C, Rigano S, Germer U, Moyano D, Turan S, Hartung J, Bhide A, Müller T, Bower S, Nicolaides KH, Thilaganathan B, Gembruch U, Ferrazzi E, Hecher K, Galan HL, Harman CR: Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109:253-261.
  8. Bilardo CM, Wolf H, Stigter RH, Ville Y, Baez E, Visser GHA, Hecher K: Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 2004;23:119-125.
  9. When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? The GRIT Study Group. Growth Restriction Intervention Trial. Eur J Obstet Gynecol Reprod Biol 1996;67:121-126.
  10. Romero R, Kalache KD, Kadar N: Timing the delivery of the preterm severely growth-restricted fetus: venous Doppler, cardiotocography or the biophysical profile? Ultrasound Obstet Gynecol 2002;19:118-121.
  11. Baschat AA: Integrated fetal testing in growth restriction: combining multivessel Doppler and biophysical parameters. Ultrasound Obstet Gynecol 2003;21:1-8.
  12. Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackelöer BJ, Kok HJ, Senat MV, Visser GH: Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001;18:564-570.
  13. Oros D, Figueras F, Cruz-Martinez R, Meler E, Munmany M, Gratacos E: Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2011;37:191-195.
  14. Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, Nicolaides KH, Harman CR, Baschat AA: Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;32:160-167.
  15. Baschat AA, Gembruch U, Harman CR: The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 2001;18:571-577.
  16. Cosmi E, Ambrosini G, D'Antona D, Saccardi C, Mari G: Doppler, cardiotocography, and biophysical profile changes in growth-restricted fetuses. Obstet Gynecol 2005;106:1240-1245.
  17. Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, Battaglia FC, Galan HL: Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002;19:140-146.
  18. Vintzileos AM, Fleming AD, Scorza WE, Wolf EJ, Balducci J, Campbell WA, Rodis JF: Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 1991;165:707-713.
  19. Cruz-Martínez R, Figueras F, Hernandez-Andrade E, Oros D, Gratacos E: Fetal brain Doppler to predict cesarean delivery for non-reassuring fetal status in term small-for-gestational-age fetuses. Obstet Gynecol 2011;117:618-626.
  20. Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L, Gratacos E: Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201-207.
  21. Bahado-Singh RO, Kovanci E, Jeffres A, Oz U, Deren O, Copel J, Mari G: The Doppler cerebroplacental ratio and perinatal outcome in intrauterine growth restriction. Am J Obstet Gynecol 1999;180:750-756.
  22. Baschat A, Berg C, Turan O, Turan S, Galan H: Natural history of stillbirth in placenta-based fetal growth restriction - implications for surveillance. Am J Obstet Gynecol 2008;1999;6(suppl A):S198.
    External Resources
  23. Hecher K, Spernol R, Stettner H, Szalay S: Potential for diagnosing imminent risk to appropriate- and small-for-gestational-age fetuses by Doppler sonographic examination of umbilical and cerebral arterial blood flow. Ultrasound Obstet Gynecol 1992;2:266-271.
  24. Robinson HP, Fleming JE: A critical evaluation of sonar ‘crown-rump length' measurements. Br J Obstet Gynaecol 1975;82:702-710.
  25. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacos E, Gardosi J: Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008;136:20-24.
  26. Arduini D, Rizzo G: Normal values of pulsatility index from fetal vessels: a cross-sectional study on 1,556 healthy fetuses. J Perinat Med 1990;18:165-172.
  27. Baschat AA, Gembruch U: The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003;21:124-127.
  28. Rizzo G, Arduini D, Romanini C: Doppler echocardiographic assessment of fetal cardiac function. Ultrasound Obstet Gynecol 1992;2:434-445.
  29. Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B, Gratacos E: Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128-132.
  30. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy 1990;163:1691-1712.
  31. Gregg AR, Weiner CP: ‘Normal' umbilical arterial and venous acid-base and blood gas values. Clin Obstet Gynecol 1993;36:24-32.
    External Resources
  32. Redline RW: Placental pathology: a systematic approach with clinical correlations. Placenta 2008;29(suppl A):S86-S91.
  33. Shih YS: Families of splitting criteria for classification trees. Statist Comput 1999;9:309-319.
    External Resources
  34. Chaddha V, Viero S, Huppertz B, Kingdom J: Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 2004;9:357-369.
  35. Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacos E: Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303-309.
  36. Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aarnoudse JG: Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001;22:405-411.
  37. Cruz-Lemini M, Crispi F, Van Mieghem T, Pedraza D, Cruz-Martínez R, Acosta-Rojas R, Figueras F, Parra-Cordero M, Deprest J, Gratacos E: Risk of perinatal death in early-onset intrauterine growth restriction according to gestational age and cardiovascular Doppler indices: a multicenter study. Fetal Diagn Ther 2012;32:116-122.
  38. Fok RY, Pavlova Z, Benirschke K, Paul RH, Platt LD: The correlation of arterial lesions with umbilical artery Doppler velocimetry in the placentas of small-for-dates pregnancies. Obstet Gynecol 1990;75:578-583.
    External Resources
  39. Comas M, Crispi F, Cruz-Martínez R, Figueras F, Gratacos E: Tissue Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age fetuses. Am J Obstet Gynecol 2011;205:57.e1-e6.
  40. Savchev S, Figueras F, Cruz-Martinez R, Illa M, Botet F, Gratacos E: Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices. Ultrasound Obstet Gynecol 2012;39:299-303.
  41. Mallard EC, Williams CE, Johnston BM, Gluckman PD: Increased vulnerability to neuronal damage after umbilical cord occlusion in fetal sheep with advancing gestation. Am J Obstet Gynecol 1994;170:206-214.
  42. Parra-Saavedra M, Crovetto F, Triunfo S, Savchev S, Parra G, Sanz M, Gratacos E, Figueras F: Added value of umbilical vein flow as a predictor of perinatal outcome in term small-for-gestational-age fetuses. Ultrasound Obstet Gynecol 2013;42:189-195.
  43. Figueras F, Eixarch E, Gratacos E, Gardosi J: Predictiveness of antenatal umbilical artery Doppler for adverse pregnancy outcome in small-for-gestational-age babies according to customised birthweight centiles: population-based study. BJOG 2008;115:590-594.
  44. Figueras F, Oros D, Cruz-Martínez R, Padilla N, Hernandez-Andrade E, Botet F, Costas-Moragas C, Gratacos E: Neurobehavior in term, small-for-gestational age infants with normal placental function. Pediatrics 2009;124:e934-e941.
  45. Savchev S, Sanz-Cortes M, Rogelio C-M, Arranz A, Francesc B, Eduard G, Francesc F: Neurodevelopmental outcome of full-term, small-for-gestational-age infants with normal placental function. Ultrasound Obstet Gynecol 2013;42:201-206.
  46. Bassan H, Stolar O, Geva R, Eshel R, Fattal-Valevski A, Leitner Y, Waron M, Jaffa A, Harel S: Intrauterine growth-restricted neonates born at term or preterm: how different? Pediatric Neurol 2011;44:122-130.
  47. Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Le Noble F, Ahmed A, Gratacos E: Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation 2010;121:2427-2436.
  48. Crispi F, Figueras F, Cruz-Lemini M, Bartrons J, Bijnens B, Gratacos E: Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol 2012;207:121.e1-e9.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: March 21, 2013
Accepted: September 06, 2013
Published online: November 06, 2013
Issue release date: August 2014

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP